middle.news
Resonance Health Lifts FY26 EBITDA Forecast by 30 Percent on Margin Gains
10:32am on Tuesday 5th of May, 2026 AEST
•
Healthcare
Read Story
Resonance Health Lifts FY26 EBITDA Forecast by 30 Percent on Margin Gains
10:32am on Tuesday 5th of May, 2026 AEST
Key Points
EBITDA guidance increased 30% to $2.6 million
Revenue guidance trimmed to $16 million due to timing
Margin expansion to 16.3% reflects operational leverage
Growth driven by SaMD segment and clinical trial services
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE